Target Name: SBSPON
NCBI ID: G157869
Review Report on SBSPON Target / Biomarker Content of Review Report on SBSPON Target / Biomarker
SBSPON
Other Name(s): SBSPO_HUMAN | somatomedin B and thrombospondin type 1 domain containing | Somatomedin B and thrombospondin type 1 domain containing | OTTHUMP00000211532 | FLJ40021 | RPE spondin | Somatomedin-B and thrombospondin type-1 domain-containing protein | RPE-spondin | C8orf84 | RPESP

SBSPON: A Protein Implicated in Pregnancy Development and Maintenance

SBSPON (SBSPO-HUMAN) is a protein that is expressed in the placenta and has been shown to play a role in the development and maintenance of pregnancy. The placenta plays a vital role in providing nutrients and oxygen to the developing fetus, and it is also responsible for removing waste products from the body. SBSPON has been shown to be involved in the regulation of these processes, and it is possible that it could be a drug target or biomarker for pregnancy-related diseases.

SBSPON is a member of the Smin family of proteins, which are known for their role in cell signaling. Smin proteins are involved in a wide range of processes in the body, including cell division, differentiation, and survival. SBSPON is specifically known for its role in the regulation of cell proliferation and survival, as well as its role in the development and maintenance of the placenta.

SBSPON has been shown to be involved in the regulation of cell proliferation and apoptosis, which are processes that are important for the growth and development of tissues in the body. During pregnancy, the placenta undergoes rapid growth and expansion to accommodate the growing fetus, and it is during this time that SBSPON is most active.

SBSPON has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body. During pregnancy, the placenta needs to grow and expand to provide adequate blood supply to the growing fetus. SBSPON is involved in this process, as it has been shown to regulate the formation of new blood vessels in the placenta.

In addition to its role in cell proliferation and angiogenesis, SBSPON has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and maintenance of pregnancy. For example, SBSPON has been shown to be involved in the regulation of the Wnt signaling pathway, which is important for the development of the neural tube, which forms the baby's brain and spinal cord.

SBSPON has also been shown to be involved in the regulation of theNotch signaling pathway, which is important for the development and maintenance of various tissues in the body. TheNotch signaling pathway is involved in the regulation of cell proliferation, differentiation, and survival, and it is thought to be important for the development and maintenance of the placenta during pregnancy.

SBSPON has also been shown to be involved in the regulation of the Hedgehog signaling pathway, which is important for the development and maintenance of the body's tissues. TheHedgehog signaling pathway is involved in the regulation of cell proliferation and survival, and it is thought to be important for the development and maintenance of the placenta during pregnancy.

In conclusion, SBSPON is a protein that is involved in the regulation of a wide range of processes that are important for the development and maintenance of pregnancy. As a result, SBSPON is a potential drug target or biomarker for pregnancy-related diseases. Further research is needed to fully understand the role of SBSPON in the development and maintenance of pregnancy, as well as its potential as a drug target or biomarker.

Protein Name: Somatomedin B And Thrombospondin Type 1 Domain Containing

The "SBSPON Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SBSPON comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SC5D | SCAANT1 | SCAF1 | SCAF11 | SCAF4 | SCAF8 | SCAI | SCAMP1 | SCAMP1-AS1 | SCAMP2 | SCAMP3 | SCAMP4 | SCAMP5 | SCAND1 | SCAND2P | SCAND3 | SCAP | SCAPER | SCARA3 | SCARA5 | SCARB1 | SCARB2 | SCARF1 | SCARF2 | SCARNA1 | SCARNA10 | SCARNA11 | SCARNA12 | SCARNA13 | SCARNA14 | SCARNA15 | SCARNA16 | SCARNA17 | SCARNA18 | SCARNA2 | SCARNA20 | SCARNA21 | SCARNA22 | SCARNA23 | SCARNA27 | SCARNA28 | SCARNA3 | SCARNA4 | SCARNA5 | SCARNA6 | SCARNA7 | SCARNA8 | SCARNA9 | SCARNA9L | SCART1 | SCAT1 | SCCPDH | SCD | SCD5 | SCDP1 | SCEL | SCF (SKP1-CUL1-F-box protein) Ubiquitin Ligase Complex | SCF Ubiquitin Ligase Complex | SCFD1 | SCFD2 | SCG2 | SCG3 | SCG5 | SCGB1A1 | SCGB1B2P | SCGB1C1 | SCGB1D1 | SCGB1D2 | SCGB1D4 | SCGB2A1 | SCGB2A2 | SCGB2B2 | SCGB3A1 | SCGB3A2 | SCGN | SCHIP1 | SCHLAP1 | SCIMP | SCIN | SCIRT | SCLT1 | SCLY | SCMH1 | SCML1 | SCML2 | SCML4 | SCN10A | SCN11A | SCN1A | SCN1A-AS1 | SCN1B | SCN2A | SCN2B | SCN3A | SCN3B | SCN4A | SCN4B | SCN5A | SCN7A | SCN8A